A Systematic Review of the Direct Economic Burden of Type 2 Diabetes in China

被引：0
|
作者：
Huimei Hu
Monika Sawhney
Lizheng Shi
Shengnan Duan
Yunxian Yu
Zhihong Wu
Guixing Qiu
Hengjin Dong
机构：
[1] Zhejiang University School of Medicine,Department of Social Medicine, Center for Health Policy Studies, Chronic Disease Research Institute, School of Public Health
[2] Zhejiang Medical College,Department of Social Medicine, Center for Health Policy Studies, School of Public Health
[3] Zhejiang Medical College,Department of Health Information Management, School of Public Health
[4] Marshall University,College of Health Professions
[5] Tulane University,School of Public Health and Tropical Medicine
[6] Dalian Medical University,Department of Epidemiology, Chronic Disease Research Institute, School of Public Health
[7] Zhejiang University School of Medicine,undefined
[8] Peking Union Medical College Hospital,undefined
[9] Peking Union Medical College and Chinese Academy of Medical Sciences,undefined
来源：
Diabetes Therapy | 2015年 / 6卷
关键词：
China; Direct economic burden; Health care costs; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：7 / 16
页数：9
相关论文
共 50 条
  • [21] SCREENING FOR TYPE 2 DIABETES MELLITUS: A SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS
    Jin, Z.
    Rothwell, J.
    Lim, K. K.
    VALUE IN HEALTH, 2024, 27 (12) : S105 - S105
  • [22] A Systematic Review of Economic Evaluations of Insulin for the Management of Type 2 Diabetes
    Gkrinia, Elvira Meni Maria
    Faour, Andrea Katrin
    Belancic, Andrej
    Bazile, Jacques
    Marland, Emma
    Vitezic, Dinko
    DIABETOLOGY, 2023, 4 (04): : 440 - 452
  • [23] Trends in economic burden of type 2 diabetes in China: Based on longitudinal claim data
    Liu, Xinyi
    Zhang, Luying
    Chen, Wen
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [24] EPIDEMIOLOGY, TREATMENT AND ECONOMIC BURDEN OF TYPE 2 DIABETES MELLITUS WITH NEPHROPATHY COMPLICATIONS IN CHINA
    Huang, Y. Y.
    Fan, W. J.
    Zhu, J. J.
    Zhan, L.
    Chen, W.
    VALUE IN HEALTH, 2012, 15 (07) : A603 - A603
  • [25] REVIEW OF ECONOMIC EVALUATION OF SAXAGLIPTIN IN TYPE2 DIABETES IN CHINA
    Zhang, C.
    Hu, C.
    Xu, L.
    VALUE IN HEALTH, 2016, 19 (07) : A898 - A899
  • [26] Economic burden of hypoglycemia in patients with Type 2 diabetes
    Liu, Shuqian
    Zhao, Yingnan
    Hempe, James M.
    Fonseca, Vivian
    Shi, Lizheng
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (01) : 47 - 51
  • [27] Economic burden of Type 2 diabetes in Iran in 2022
    Mohammadi, Amin
    Goharimehr, Mahshad
    Darvishi, Ali
    Heshmat, Ramin
    Esfahani, Ensieh Nasli
    Shafiee, Gita
    Ostovar, Afshin
    Daroudi, Rajabali
    BMC PUBLIC HEALTH, 2025, 25 (01)
  • [28] ECONOMIC BURDEN OF TYPE 2 DIABETES MELLITUS FOR MEXICO
    Soto-Molina, H.
    Diaz Martinez, J.
    Ceballos, R.
    VALUE IN HEALTH, 2015, 18 (07) : A863 - A864
  • [29] The economic burden of obesity worldwide: a systematic review of the direct costs of obesity
    Withrow, D.
    Alter, D. A.
    OBESITY REVIEWS, 2011, 12 (02) : 131 - 141
  • [30] The Economic Burden Of Gout: A Systematic Review Of Direct and Indirect Costs.
    Rai, Sharan
    Haji, Aliya
    Burns, Lindsay C.
    Choi, Hyon K.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S85 - S86
12345